Editorial: Genome Editing to Treat Cystic Fibrosis and Other Pulmonary Diseases

Front Genome Ed. 2022 Jun 9:4:917916. doi: 10.3389/fgeed.2022.917916. eCollection 2022.

Authors

S Vaidyanathan¹, A L Ryan²

Affiliations

¹ Department of Pediatrics, Stanford University, Stanford, CA, United States.
² Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.

No abstract available

Keywords: airway; basal cells; cell therapy; cystic fibrosis; engraftment; gene editing (CRISPR/Cas9).

Publication types

Editorial